Method of inducing a CTL response

Details Method of inducing a CTL response Method of inducing a CTL response

2005-12-20

2005-12-20

Chan, Christina (Department: 1644)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Animal or plant cell

C424S184100, C424S186100, C424S190100, C424S199100, C424S200100, C424S534000, C435S007230, C435S007240, C435S007930, C435S236000, C435S252000, C435S325000, C514S04400A, C530S300000, C530S350000, C530S351000, C536S023500

Reexamination Certificate

active

06977074

ABSTRACT:
Disclosed herein are methods for inducing an immunological CTL response to an antigen by sustained, regular delivery of the antigen to a mammal so that the antigen reaches the lymphatic system. Antigen is delivered at a level sufficient to induce an immunologic CTL response in a mammal and the level of the antigen in the mammal's lymphatic system is maintained over time sufficient to maintain the immunologic CTL response. Also disclosed is an article of manufacture for delivering an antigen that induces a CTL response in an animal.

REFERENCES:
patent: 3604417 (1971-09-01), Stolzenberg et al.
patent: 3732865 (1973-05-01), Higuchi et al.
patent: 3760804 (1973-09-01), Higuchi et al.
patent: 3760805 (1973-09-01), Higuchi
patent: 3760984 (1973-09-01), Theeuwes
patent: 3929132 (1975-12-01), Higuchi
patent: 3987790 (1976-10-01), Eckenhoff et al.
patent: 3995631 (1976-12-01), Higuchi et al.
patent: 3995632 (1976-12-01), Nakano et al.
patent: 4034756 (1977-07-01), Higuchi et al.
patent: 4203440 (1980-05-01), Theeuwes
patent: 4286067 (1981-08-01), Theeuwes
patent: 4300558 (1981-11-01), Eckenhoff et al.
patent: 4304232 (1981-12-01), Michaels
patent: 4340048 (1982-07-01), Eckenhoff
patent: 4340054 (1982-07-01), Michaels
patent: 4350271 (1982-09-01), Eckenhoff
patent: 4367741 (1983-01-01), Michaels
patent: 4435173 (1984-03-01), Siposs et al.
patent: 4439199 (1984-03-01), Amkraut et al.
patent: 4450198 (1984-05-01), Michaels
patent: 4455145 (1984-06-01), Theeuwes
patent: 4474575 (1984-10-01), Eckenhoff et al.
patent: 4498843 (1985-02-01), Schneider et al.
patent: 4526569 (1985-07-01), Bernardi
patent: 4552651 (1985-11-01), Sandbrook et al.
patent: 4561856 (1985-12-01), Cochran
patent: 4619652 (1986-10-01), Eckenhoff et al.
patent: 4643723 (1987-02-01), Smit
patent: 4753651 (1988-06-01), Eckenhoff
patent: 4767628 (1988-08-01), Hutchinson
patent: 4838862 (1989-06-01), Baker et al.
patent: 4855141 (1989-08-01), Eckenhoff et al.
patent: 4865598 (1989-09-01), Eckenhoff
patent: 4865845 (1989-09-01), Eckenhoff et al.
patent: 4872873 (1989-10-01), Zingerman
patent: 4898582 (1990-02-01), Faste
patent: 4908433 (1990-03-01), Mertelsmann et al.
patent: 4929233 (1990-05-01), Roth et al.
patent: 4963141 (1990-10-01), Eckenhoff
patent: 4976966 (1990-12-01), Theeuwes et al.
patent: 5017381 (1991-05-01), Maruyama et al.
patent: 5023088 (1991-06-01), Wong et al.
patent: 5030216 (1991-07-01), Theeuwes et al.
patent: 5034229 (1991-07-01), Magruder et al.
patent: 5037420 (1991-08-01), Magruder et al.
patent: 5057318 (1991-10-01), Magruder et al.
patent: 5059423 (1991-10-01), Magruder et al.
patent: 5110596 (1992-05-01), Magruder et al.
patent: 5110597 (1992-05-01), Wong et al.
patent: 5135498 (1992-08-01), Kam et al.
patent: 5135523 (1992-08-01), Magruder et al.
patent: 5137727 (1992-08-01), Eckenhoff
patent: 5169390 (1992-12-01), Athayde et al.
patent: 5174999 (1992-12-01), Magruder et al.
patent: 5209746 (1993-05-01), Balaban et al.
patent: 5221278 (1993-06-01), Linkwitz et al.
patent: 5223265 (1993-06-01), Wong
patent: 5257987 (1993-11-01), Athayde et al.
patent: 5286254 (1994-02-01), Shapland et al.
patent: 5304165 (1994-04-01), Haber et al.
patent: 5368562 (1994-11-01), Blomquist et al.
patent: 5478556 (1995-12-01), Elliott et al.
patent: 5496360 (1996-03-01), Hoffmann et al.
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5589466 (1996-12-01), Felgner et al.
patent: 5679647 (1997-10-01), Carson et al.
patent: 5696079 (1997-12-01), Lane et al.
patent: 5698396 (1997-12-01), Pfreundschuh
patent: 5733548 (1998-03-01), Restifo et al.
patent: 5744316 (1998-04-01), Lethe et al.
patent: 5747269 (1998-05-01), Rammensee et al.
patent: 5766601 (1998-06-01), Ennis
patent: 5830452 (1998-11-01), Bauer et al.
patent: 5846540 (1998-12-01), Restifo et al.
patent: 5853719 (1998-12-01), Nair et al.
patent: 5856187 (1999-01-01), Restifo et al.
patent: 5962428 (1999-10-01), Carrano et al.
patent: 6037135 (2000-03-01), Kubo et al.
patent: 6204250 (2001-03-01), Bot et al.
patent: 6214804 (2001-04-01), Felgner et al.
patent: 6419931 (2002-07-01), Vitiello et al.
patent: 2147863 (1994-05-01), None
patent: 74899 (1997-08-01), None
patent: WO 92/21033 (1992-11-01), None
patent: 93/03175 (1995-04-01), None
patent: WO 95/17167 (1995-06-01), None
patent: WO 96/01429 (1996-01-01), None
patent: WO 96/27008 (1996-09-01), None
patent: WO 96/40209 (1996-12-01), None
patent: WO 98/13489 (1998-04-01), None
patent: WO 98/14464 (1998-04-01), None
patent: WO 98/27963 (1998-07-01), None
patent: WO 98/43611 (1998-10-01), None
patent: WO 99/02183 (1999-01-01), None
Stryer et al, in Biochemistry, Third Edition, W H Freeman Company, New York, pp. 31-33, 1998.
Ngo et al, 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Attwood et al, The Babel of Bioinformatics, 2000, Science vol. 290 No 5491: 471-473.
Skolnick et al, From genes to protein structure and function: novel applications of computational approaches in the genomic er Jan., 2000, TIBTECH 18:34-39.
Koga et al, International Archives of Allergy and Applied Immunology 51(3): 359-67, 1976, Abstract.
Klavinskis et al, J Immunol 157(6): 2521-7, Sep. 1996.
Coupey et al, Cytokine 5(6): 564-9, Nov 1993.
Zinkernagel et al, Immunol Rev 156: 199-209, Apr. 1997.
Grohmann et al, J Immunol Methods 137(1): 9-15, Mar. 1991.
Issekutz et al, Clin Exp Immunol 56(3): 515-23, Jun. 1984.
Sadao et al, Biotherapy 9(7): 845-851, 1995; in Japanese with English Translation.
Kundig, T.M., “A Method to increase the Immunogenicity of vaccines,”Schweiz. Rundsch. Med. Prax., 89(37):1477-1484 (Sep. 2000) (German with English Summary).
Schott, M. et al., “Induction of cellular immunity in a parathyroid carcinoma treated with tumor lysate-pulsed dendritic cells,”Eur. J. Endocrinology, 142(3):300-306 (Mar. 2000).
Sedlik, C., et al., “Recombinant parvovirus-like particles as an antigen carrier: A novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells,”Proc. Natl. Acad. Sci. USA, vol. 94, pp. 7503-7508, (1997).
Bachmann, M.F., et al. (1994) In vitro vs. in vivo assays for the assessment of T-and B cell function. Curr. Opin. Immunol. 6:320-326.
Cleland, J.L., et al. (1994) Formulation and delivery of proteins and peptides. American Chemical Society, ACS Symposium Series No. 567.
Courvalian, P. et al. (1995) Life Sci. 316:1207-1212.
Dietrich, G. et al. (1998) Biotechnology 16:181-185.
Durrant LG (1997) Cancer vaccines. Anti-cancer drugs, 8:727-733.
Grohmann, U. et al. (1991) Intrasplenic immunization for the induction of humoral and cell-mediated immunity to nitrocellulose-bound antigen. Journal of Immunological Methods, 137:9-15.
Haynes, B. F. et al. (1996) Toward and understanding of the correlates of protective immunity to HIV infection. Science, 271:324-327.
Inaba, K., et al. (1992) Identification of proliferating dendritic cell precursors in mouse blood. Journal of Experimental Medicine. 175:1157-1167.
Jager, E., et al. (1996) Granulocyte-macrophage-colony-stimulating factor enhances Immune responses to melanoma-associated peptides In vivo. Int. J. Cancer, 67:54-62.
Jager, E. et al. (1996) Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding Peptide Epitopes. J.Exp.Med. 187:265-270.
Kundig, T.M. et al, (1992) Skin test to assess virus-specific cytotoxic T-cell activity. Proc. Natl. Acad. Sci. 89:7757-7761.
Kundig, T.M. et al. (1995) Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science. 266:1343-1347.
Kundig, T.M. et al. (1996) On the role of antigen in maintaining cytotoxid T cell memory. Proc. Natl. Acad. Sci. 93:9716-9723.
Moskophidis D. et al. (1995) Immunobiology of Cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus. Journal of Virology, 69:4:2187-2193.
Oehen S. et al. (1992) Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen. J.Exp.Med. 176:1273-1281.
Oldstone, M. et al. (1995) Discriminated

Affiliated with

Also associated with

Rating

Method of inducing a CTL response does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of inducing a CTL response, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inducing a CTL response will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3472690